MA51222A - Polymorphes et formes solides d'un composé de pyrimidinylamino-pyrazole, et procédés de production - Google Patents
Polymorphes et formes solides d'un composé de pyrimidinylamino-pyrazole, et procédés de productionInfo
- Publication number
- MA51222A MA51222A MA051222A MA51222A MA51222A MA 51222 A MA51222 A MA 51222A MA 051222 A MA051222 A MA 051222A MA 51222 A MA51222 A MA 51222A MA 51222 A MA51222 A MA 51222A
- Authority
- MA
- Morocco
- Prior art keywords
- pyrimidinylamino
- polymorphs
- production processes
- solid forms
- pyrazole compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762589276P | 2017-11-21 | 2017-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA51222A true MA51222A (fr) | 2020-10-07 |
Family
ID=66631734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA051222A MA51222A (fr) | 2017-11-21 | 2018-11-20 | Polymorphes et formes solides d'un composé de pyrimidinylamino-pyrazole, et procédés de production |
Country Status (22)
Country | Link |
---|---|
US (3) | US10370361B2 (fr) |
EP (1) | EP3717473B1 (fr) |
JP (1) | JP7303821B2 (fr) |
KR (1) | KR20200089713A (fr) |
CN (1) | CN111819174A (fr) |
AR (1) | AR113893A1 (fr) |
AU (1) | AU2018372180B2 (fr) |
BR (1) | BR112020010215A2 (fr) |
CA (1) | CA3083022A1 (fr) |
CL (1) | CL2020001346A1 (fr) |
CO (1) | CO2020006206A2 (fr) |
CR (1) | CR20200216A (fr) |
EA (1) | EA202091279A1 (fr) |
IL (1) | IL274824A (fr) |
JO (1) | JOP20200128A1 (fr) |
MA (1) | MA51222A (fr) |
MX (1) | MX2020005332A (fr) |
PE (1) | PE20210157A1 (fr) |
SG (1) | SG11202004733WA (fr) |
TW (1) | TWI823878B (fr) |
UA (1) | UA126414C2 (fr) |
WO (1) | WO2019104086A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3083022A1 (fr) | 2017-11-21 | 2019-05-31 | Denali Therapeutics Inc. | Polymorphes et formes solides d'un compose de pyrimidinylamino-pyrazole, et procedes de production |
EP3727377B1 (fr) | 2017-12-20 | 2024-01-31 | Denali Therapeutics Inc. | Procédé de préparation de composés pyrimidinyl-4-aminopyrazole |
WO2023174946A1 (fr) | 2022-03-15 | 2023-09-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Méthode précoce et non invasive d'évaluation du risque de maladie de parkinson chez un sujet |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201910912TA (en) | 2010-05-21 | 2020-01-30 | Incyte Corp | Topical Formulation for a JAK Inhibitor |
CA2797947C (fr) | 2010-06-04 | 2019-07-09 | Charles Baker-Glenn | Derives d'aminopyrimidine au titre de modulateurs de lrrk2 |
GB201015949D0 (en) | 2010-09-22 | 2010-11-03 | Medical Res Council Technology | Compounds |
HUE046617T2 (hu) * | 2010-11-10 | 2020-03-30 | Genentech Inc | Pirazol-aminopirimidin-származékok mint LRRK2 modulátorok |
BR112014011850B1 (pt) | 2011-11-29 | 2022-01-11 | Genentech, Inc | Derivados de aminopirimidina, seus usos, e composição farmacêutica |
EP3121173A1 (fr) | 2011-11-29 | 2017-01-25 | F. Hoffmann-La Roche AG | Dérivés d'aminopyrimidine comme modulateurs lrrk2 |
AR089182A1 (es) | 2011-11-29 | 2014-08-06 | Hoffmann La Roche | Derivados de aminopirimidina como moduladores de lrrk2 |
CA2850705C (fr) | 2011-11-29 | 2020-03-10 | F. Hoffmann-La Roche Ag | Derives 2-(phenyl ou pyrid-3-yl)aminopyrimidines en tant que modulateurs de la kinase lrrk2 pour le traitement de la maladie de parkinson |
MX363118B (es) * | 2012-05-03 | 2019-03-11 | Genentech Inc | Derivados de pirazol aminopirimidina como moduladores de cinasa 2 de repeticion rica en leucina (lrrk2). |
WO2013164323A1 (fr) | 2012-05-03 | 2013-11-07 | F. Hoffmann-La Roche Ag | Dérivés de pyrazole aminopyrimidine en tant que modulateurs de lrrk2 destinés à être utilisés dans le traitement de la maladie de parkinson |
KR20230107407A (ko) | 2016-06-16 | 2023-07-14 | 데날리 테라퓨틱스 인크. | 신경퇴행성 장애의 치료에서 사용하기 위한 lrrk2 저해제로서피리미딘-2-일아미노-1h-피라졸 |
CA3083022A1 (fr) | 2017-11-21 | 2019-05-31 | Denali Therapeutics Inc. | Polymorphes et formes solides d'un compose de pyrimidinylamino-pyrazole, et procedes de production |
-
2018
- 2018-11-20 CA CA3083022A patent/CA3083022A1/fr active Pending
- 2018-11-20 CN CN201880081321.5A patent/CN111819174A/zh active Pending
- 2018-11-20 MA MA051222A patent/MA51222A/fr unknown
- 2018-11-20 CR CR20200216A patent/CR20200216A/es unknown
- 2018-11-20 AU AU2018372180A patent/AU2018372180B2/en active Active
- 2018-11-20 UA UAA202003681A patent/UA126414C2/uk unknown
- 2018-11-20 US US16/197,037 patent/US10370361B2/en active Active
- 2018-11-20 KR KR1020207017598A patent/KR20200089713A/ko not_active Application Discontinuation
- 2018-11-20 TW TW107141257A patent/TWI823878B/zh active
- 2018-11-20 WO PCT/US2018/062102 patent/WO2019104086A1/fr active Application Filing
- 2018-11-20 EP EP18881859.5A patent/EP3717473B1/fr active Active
- 2018-11-20 PE PE2020000558A patent/PE20210157A1/es unknown
- 2018-11-20 MX MX2020005332A patent/MX2020005332A/es unknown
- 2018-11-20 BR BR112020010215-6A patent/BR112020010215A2/pt unknown
- 2018-11-20 EA EA202091279A patent/EA202091279A1/ru unknown
- 2018-11-20 JO JOP/2020/0128A patent/JOP20200128A1/ar unknown
- 2018-11-20 SG SG11202004733WA patent/SG11202004733WA/en unknown
- 2018-11-20 JP JP2020545076A patent/JP7303821B2/ja active Active
- 2018-11-20 AR ARP180103389A patent/AR113893A1/es unknown
-
2019
- 2019-06-20 US US16/447,713 patent/US10851088B2/en active Active
-
2020
- 2020-05-20 IL IL274824A patent/IL274824A/en unknown
- 2020-05-21 CO CONC2020/0006206A patent/CO2020006206A2/es unknown
- 2020-05-21 CL CL2020001346A patent/CL2020001346A1/es unknown
- 2020-11-27 US US17/105,870 patent/US11427571B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
SG11202004733WA (en) | 2020-06-29 |
UA126414C2 (uk) | 2022-09-28 |
MX2020005332A (es) | 2021-01-08 |
EP3717473B1 (fr) | 2024-01-10 |
IL274824A (en) | 2020-07-30 |
AU2018372180A1 (en) | 2020-06-18 |
EP3717473A1 (fr) | 2020-10-07 |
JOP20200128A1 (ar) | 2020-05-21 |
US10370361B2 (en) | 2019-08-06 |
WO2019104086A1 (fr) | 2019-05-31 |
CL2020001346A1 (es) | 2020-11-20 |
US20210087176A1 (en) | 2021-03-25 |
CN111819174A (zh) | 2020-10-23 |
AU2018372180B2 (en) | 2023-08-17 |
KR20200089713A (ko) | 2020-07-27 |
EP3717473A4 (fr) | 2021-07-07 |
CO2020006206A2 (es) | 2020-08-10 |
CA3083022A1 (fr) | 2019-05-31 |
US10851088B2 (en) | 2020-12-01 |
US11427571B2 (en) | 2022-08-30 |
JP2021504450A (ja) | 2021-02-15 |
PE20210157A1 (es) | 2021-01-26 |
JP7303821B2 (ja) | 2023-07-05 |
BR112020010215A2 (pt) | 2020-11-03 |
AR113893A1 (es) | 2020-06-24 |
TW201925190A (zh) | 2019-07-01 |
CR20200216A (es) | 2021-03-19 |
TWI823878B (zh) | 2023-12-01 |
US20190194170A1 (en) | 2019-06-27 |
US20190315723A1 (en) | 2019-10-17 |
EA202091279A1 (ru) | 2020-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA47575A (fr) | Composés inhibiteurs d'oga monocyclique | |
MA41514A (fr) | Procédés intégrés de synthèse chimique | |
MA41200B1 (fr) | Procédé pour la préparation d'un composé diarylthiohydantoïne | |
DK3497081T3 (da) | Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte | |
MA41203A (fr) | Procédés pour la préparation d'un composé diaryl-thiohydantoïne | |
MA51222A (fr) | Polymorphes et formes solides d'un composé de pyrimidinylamino-pyrazole, et procédés de production | |
DK3390354T3 (da) | Fremgangsmåde til tilvejebringelse af carbondioxid til syntese af urea | |
DK3568403T3 (da) | Kemiske forbindelser til belægning af nanostrukturer | |
MA50647A (fr) | Procédé de régulation d'un puits | |
MA50169A (fr) | Procédé de production d'un électrocatalyseur | |
EP3341364C0 (fr) | Procédé pour la préparation d'un composé à double effet inhibiteur de la néprilysine-récepteur de l'angiotensine | |
MA45588A (fr) | Formes solides d'un stimulateur de la gcs | |
DK3390407T3 (da) | Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser | |
HRP20202039T8 (hr) | Postupci za kemijsku sintezu supstituiranih 10h-fenotiazin-3,7-diaminskih spojeva | |
WO2015124764A8 (fr) | Procédé de synthèse de dabigatran étexilate mésylate, intermédiaires de ce procédé et nouveau polymorphe de dabigatran étexilate | |
MA42423A (fr) | Procédé de préparation d'un revêtement | |
IL268456B (en) | A new process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes | |
GB201809018D0 (en) | Identification of chemical structures | |
MA44680A (fr) | Compositions et procédés pour la production de composés | |
DK3495339T3 (da) | Fremgangsmåde til fremstilling af reaktionsprodukt | |
FR3020136B1 (fr) | Installation de surveillance d'un ouvrage | |
DK3515454T3 (da) | Krystallinsk polymorf form af 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2lambda5-[1,2]oxaphosphinan | |
IT201700102990A1 (it) | Metodo per l’ottenimento di un target solido per la produzione di radiofarmaci | |
IT201700059261A1 (it) | Piatto compostabile e procedimento per la produzione di un piatto compostabile. | |
MA41599A (fr) | Formes cristallines d'un composé pyrrolopyridine |